Economic evaluation of gemcitabine in the treatment of pancreatic cancer in the UK: How important is quality of life?

Nick Bansback, Sue Ward, Jonathan Karnon

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)
Original languageEnglish
Pages (from-to)188-189
Number of pages2
JournalThe European Journal of Health Economics
Volume5
Issue number2
DOIs
Publication statusPublished - May 2004
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Gemcitabine
  • Economic evaluation
  • Expected value of information

Cite this